Literature DB >> 15029499

Glaucoma and mortality.

Kirsti Grødum1, Anders Heijl, Bo Bengtsson.   

Abstract

PURPOSE: To compare mortality rates in glaucoma patients and matched controls from a large population screening as well as glaucoma patients diagnosed through routine clinical examination (self-selected patients).
METHODS: A population-based screening of 32,918 elderly citizens of Malmö was conducted between 1992 and 1997. Individuals with newly detected, previously untreated open-angle glaucoma were identified. Two controls of the same age and gender were chosen among the screening negative participants for each patient. From the same birth cohorts, glaucoma patients seen in routine clinical practice (self-selected patients) were identified through retrospective examination of patient records from the Eye Department at Malmö University Hospital. The number and time of deaths for each group were determined based on centrally administered registers.
RESULTS: Mean follow-up time was 7.75 years. Five-year mortality did not differ significantly between the groups, and was 9.2% among glaucoma patients from the screening (n=402), and 11.9% among the controls (n=804; p=0.7406). Self-selected glaucoma patients had a 5-year mortality of 8.5% (n=354), not significantly different from the screening-detected glaucoma patients (p=0.1361). Among glaucoma patients, neither IOP (p=0.1781) nor pseudoexfoliation (p=0.8882) was related to significantly increased mortality.
CONCLUSIONS: The results of this study strongly suggest that the life expectancy of glaucoma patients does not differ from the population at large.

Entities:  

Mesh:

Year:  2004        PMID: 15029499     DOI: 10.1007/s00417-004-0858-2

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  36 in total

Review 1.  Antiglaucoma medications: a review of safety and tolerability issues related to their use.

Authors:  J S Schuman
Journal:  Clin Ther       Date:  2000-02       Impact factor: 3.393

Review 2.  New definitions of glaucoma.

Authors:  N Gupta; R N Weinreb
Journal:  Curr Opin Ophthalmol       Date:  1997-04       Impact factor: 3.761

3.  Evaluation of the clinical association between exfoliation syndrome and abdominal aortic aneurysm.

Authors:  Jaana Hietanen; Sari Soisalon-Soininen; Tero Kivelä; Ahti Tarkkanen
Journal:  Acta Ophthalmol Scand       Date:  2002-12

4.  A comparison of glaucoma patients identified through mass screening and in routine clinical practice.

Authors:  Kirsti Grødum; Anders Heijl; Bo Bengtsson
Journal:  Acta Ophthalmol Scand       Date:  2002-12

5.  Studies of factors involved in the production of low tension glaucoma.

Authors:  S M Drance; V P Sweeney; R W Morgan; F Feldman
Journal:  Arch Ophthalmol       Date:  1973-06

6.  Early Manifest Glaucoma Trial: design and baseline data.

Authors:  M C Leske; A Heijl; L Hyman; B Bengtsson
Journal:  Ophthalmology       Date:  1999-11       Impact factor: 12.079

7.  The effect of topical clonidine on intraocular pressure.

Authors:  E Hodapp; A E Kolker; M A Kass; I Goldberg; B Becker; M Gordon
Journal:  Arch Ophthalmol       Date:  1981-07

Review 8.  Vascular aspects in the pathophysiology of glaucomatous optic neuropathy.

Authors:  H S Chung; A Harris; D W Evans; L Kagemann; H J Garzozi; B Martin
Journal:  Surv Ophthalmol       Date:  1999-06       Impact factor: 6.048

9.  Glaucoma and survival: the National Health Interview Survey 1986-1994.

Authors:  David J Lee; Orlando Gómez-Marín; Byron L Lam; D Diane Zheng
Journal:  Ophthalmology       Date:  2003-08       Impact factor: 12.079

10.  Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.

Authors:  Anders Heijl; M Cristina Leske; Bo Bengtsson; Leslie Hyman; Boel Bengtsson; Mohamed Hussein
Journal:  Arch Ophthalmol       Date:  2002-10
View more
  16 in total

1.  Pseudoexfoliation syndrome: analysis of systemic comorbidities of 325 PEX-positive patients compared with 911 PEX-negative patients.

Authors:  Elizabeth Scharfenberg; Franziska G Rauscher; Petra Meier; Dirk Hasenclever
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-08-16       Impact factor: 3.117

2.  Genetics, Diagnosis, and Monitoring of Pseudoexfoliation Glaucoma.

Authors:  Niraj Nathan; Rachel W Kuchtey
Journal:  Curr Ophthalmol Rep       Date:  2016-10-11

Review 3.  [PEX syndrome. Clinical diagnosis and systemic manifestations].

Authors:  E Scharfenberg; U Schlötzer-Schrehardt
Journal:  Ophthalmologe       Date:  2012-10       Impact factor: 1.059

Review 4.  Pharmacotherapy and Adherence Issues in Treating Elderly Patients with Glaucoma.

Authors:  David C Broadway; Heidi Cate
Journal:  Drugs Aging       Date:  2015-07       Impact factor: 3.923

5.  Association of ocular pseudoexfoliation syndrome with ischaemic heart disease, arterial hypertension and diabetes mellitus.

Authors:  Martynas Spečkauskas; Abdonas Tamošiūnas; Vytautas Jašinskas
Journal:  Acta Ophthalmol       Date:  2012-05-02       Impact factor: 3.761

6.  Ten-year outcomes in newly diagnosed glaucoma patients: mortality and visual function.

Authors:  Tarun Sharma; John F Salmon
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

7.  Increase of carotid artery stiffness and decrease of baroreflex sensitivity in exfoliation syndrome and glaucoma.

Authors:  Z Visontai; B Merisch; M Kollai; G Holló
Journal:  Br J Ophthalmol       Date:  2006-02-17       Impact factor: 4.638

8.  Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data.

Authors:  Aimee Teo Broman; Harry A Quigley; Sheila K West; Joanne Katz; Beatriz Munoz; Karen Bandeen-Roche; James M Tielsch; David S Friedman; Jonathan Crowston; Hugh R Taylor; Rohit Varma; M Cristina Leske; Boel Bengtsson; Anders Heijl; Mingguang He; Paul J Foster
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

9.  Incorporating mortality risk into estimates of 5-year glaucoma risk.

Authors:  Beth Ann Griffin; Marc N Elliott; Anne L Coleman; Eric M Cheng
Journal:  Am J Ophthalmol       Date:  2009-10-02       Impact factor: 5.258

Review 10.  Pseudoexfoliation syndrome and cardiovascular diseases.

Authors:  Georgios K Andrikopoulos; Dimitrios K Alexopoulos; Sotirios P Gartaganis
Journal:  World J Cardiol       Date:  2014-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.